Reopening America

Trying to Stay Ahead of Coronavirus Variants, Companies Still Rushing to Develop COVID Drugs

Companies are still in a rush working on drugs that can help treat COVID-19 and stay ahead of new, more transmissible variants that are popping up all over. Monoclonal antibody drugs are administered intravenously making them a little cumbersome, and some are working on new ones that are more accessible and maybe given as a shot. Joseph Walker, reporter at the WSJ, joins us for the race to stay ahead of coronavirus mutations. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.